Denali Advisors LLC lowered its stake in Amdocs Limited (NASDAQ:DOX) by 3.0% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 98,700 shares of the technology company’s stock after selling 3,100 shares during the period. Denali Advisors LLC’s holdings in Amdocs were worth $6,525,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently bought and sold shares of DOX. JPMorgan Chase & Co. boosted its stake in Amdocs by 13.0% during the first quarter. JPMorgan Chase & Co. now owns 135,495 shares of the technology company’s stock worth $7,332,000 after buying an additional 15,600 shares during the last quarter. First Trust Advisors LP raised its stake in Amdocs by 173.3% during the 1st quarter. First Trust Advisors LP now owns 810,646 shares of the technology company’s stock valued at $43,864,000 after purchasing an additional 514,053 shares during the period. Xact Kapitalforvaltning AB acquired a new stake in Amdocs during the 1st quarter valued at $631,000. MML Investors Services LLC raised its stake in Amdocs by 42.8% during the 1st quarter. MML Investors Services LLC now owns 17,825 shares of the technology company’s stock valued at $965,000 after purchasing an additional 5,340 shares during the period. Finally, Neuberger Berman Group LLC raised its stake in Amdocs by 6.4% during the 1st quarter. Neuberger Berman Group LLC now owns 992,197 shares of the technology company’s stock valued at $53,687,000 after purchasing an additional 59,832 shares during the period. 92.00% of the stock is currently owned by institutional investors.
Shares of NASDAQ DOX traded up $0.40 during mid-day trading on Wednesday, reaching $65.68. The company had a trading volume of 449,202 shares, compared to its average volume of 878,169. Amdocs Limited has a twelve month low of $52.60 and a twelve month high of $67.57. The stock has a market capitalization of $9.11 billion, a PE ratio of 17.56, a price-to-earnings-growth ratio of 1.82 and a beta of 0.39. The stock’s 50 day moving average is $65.48 and its 200-day moving average is $60.96.
The business also recently declared a quarterly dividend, which will be paid on Friday, October 25th. Stockholders of record on Monday, September 30th will be paid a $0.285 dividend. This represents a $1.14 dividend on an annualized basis and a dividend yield of 1.74%. The ex-dividend date is Friday, September 27th. Amdocs’s dividend payout ratio (DPR) is presently 30.48%.
Several analysts have issued reports on DOX shares. BidaskClub raised shares of Amdocs from a “buy” rating to a “strong-buy” rating in a research note on Friday, October 4th. JPMorgan Chase & Co. boosted their target price on shares of Amdocs from $67.00 to $75.00 and gave the company a “neutral” rating in a research note on Thursday, August 8th. Finally, Zacks Investment Research downgraded shares of Amdocs from a “buy” rating to a “hold” rating and set a $67.00 target price on the stock. in a research note on Tuesday, July 16th. Three research analysts have rated the stock with a hold rating and one has given a strong buy rating to the company. The company has an average rating of “Buy” and an average target price of $71.00.
Amdocs Company Profile
Amdocs Limited, through its subsidiaries, provides software and services to the communications, pay TV, entertainment, and media industry service providers worldwide. The company offers amdocsONE a line of services designed for various stages of a service provider's lifecycle, including planning, delivery, implementation, and ongoing support, as well as consumer experience and monetization, media and digital, enterprise and connected society, service-driven network, and services and agile operation solutions.
Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX).
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.